- Centers & Specialties
- Clinical Interests
- Neurocritical Care
- Subarachnoid hemorrhage
- Medical Education
- MD, PhD, Harvard Medical School
- Residency, Brigham and Women's Hospital|Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
W. Taylor Kimberly, MD PhD is a stroke and critical care neurologist in the Department of Neurology. He serves as the Associate Director of the MGH Neuroscience Intensive Care Unit and is an Assistant Professor of Neurology at Harvard Medical School.
Clinically, he cares for patients in the Neuroscience intensive care unit as part of an integrated and multi-disciplinary team model with Neurosurgery and Neuroendovascular specialists. He works on several hospital-based and national committees that focus on clinical guideline development and quality improvement.
Dr. Kimberly's research group is located in the Center for Human Genetic Research, and studies blood-based and neuroimaging biomarkers of subarachnoid hemorrhage, stroke and cerebral edema. Through the use of metabolomics and neuroimaging, the goal is to identify novel therapeutic targets for acute brain injury. Dr. Kimberly also co-leads a phase II multi-site, randomized, placebo-controlled trial that is evaluating the safety and efficacy of a novel compound in preventing brain edema.
Wolfe MS et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and g-secretase activity. Nature, 398:513-517 (1999).
Kimberly WT et al. g-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1 and pen-2. Proc. Natl. Acad. Sci. U.S.A., 100:6382-6387 (2003).
Singhal AS et al. Case Records of the Massachusetts General Hospital. A 36-year-old woman with headache, hypertension, and seizure 2 weeks post-partum. New Engl. J. Med., 360:1126-1137 (2009).
Kimberly WT et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology, 72:1230-1235 (2009).
Kimberly WT et al. Lower hemoglobin correlates with larger stroke volumes in acute ischemic stroke. Cerebrovasc. Dis. Extra, 1:44-53 (2011).
O'Connor SG et al. Process improvement methods increase the efficiency, accuracy and utility of a neurocritical care research repository. Neurocrit. Care, 17:90-96 (2012).
Kimberly et al. Sex differences and hemoglobin levels in relation to stroke outcomes. Neurology, 80: in press (2013).
55 Fruit Street
Boston MA, 02114-2696
15 Parkman Street
Boston MA, 02114-3117